Ani Pharmaceuticals announced that the Food and Drug Administration (FDA) has approved the Abbreviated New Drug Application (ANDA) for Polyethylene Glycol 3350 Powder for Oral Solution. 

RELATED: Gastrohepatic Disorders Resource Center

Polyethylene Glycol 3350 Powder for Oral Solution is an osmotic indicated for the treatment of occasional constipation. Polyethylene glycol works by retaining water in the stool, resulting in softer stools and more frequent bowel movements. Polyethylene glycol does not affect glucose and electrolytes in the body.

It will be be available as a 17mg per scoopful.  

For more information call or visit Anipharmaceuticals.com.